Wells Fargo raised the firm’s price target on Calumet Specialty Products (CLMT) to $29 from $25 and keeps an Overweight rating on the shares. The firm says lower cost with greater financial capacity should deliver greater earnings power and cashflow generation with visibility into 2028. Near-term valuation is attractive with longer-term valuation potential to $40, Wells adds.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLMT:
- Calumet Specialty Products price target raised to $27 from $22 at TD Cowen
- Closing Bell Movers: Alcoa up 6%, Steel Dynamics up 3% after Q3 results
- Calumet Specialty Products announces DOE commitment for loan of up to $1.44B
- Calumet Specialty Products announces new funding agreement with Stonebriar
- Calumet agreements could be path to DOE loan, says Wainwright